BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 33272734)

  • 21. PPARα/γ agonists and antagonists differently affect hepatic lipid metabolism, oxidative stress and inflammatory cytokine production in steatohepatitic rats.
    Zhang Y; Cui Y; Wang XL; Shang X; Qi ZG; Xue J; Zhao X; Deng M; Xie ML
    Cytokine; 2015 Sep; 75(1):127-35. PubMed ID: 26194065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Obesity-Induced Upregulation of ZBTB7A Promotes Lipid Accumulation through SREBP1.
    Zhou JP; Ren YD; Xu QY; Song Y; Zhou F; Chen MY; Liu JJ; Chen LG; Pan JS
    Biomed Res Int; 2020; 2020():4087928. PubMed ID: 31998789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. (+)Alpha-Lipoic Acid Regulates Lipid Metabolism Gene Expression and Lipidic Profile in a Cellular Model of Fatty Acid Overload.
    Longhitano L; Tibullo D; Zuppelli T; Ronsisvalle S; La Spina E; Nicolosi A; Antoci M; Sipala FM; Galvano F; Currenti W; Santisi A; Alanazi AM; Zanghì G; Tropea E; Li Volti G; Barbagallo IA
    Front Biosci (Landmark Ed); 2024 Jun; 29(6):209. PubMed ID: 38940024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Silibinin ameliorates hepatic lipid accumulation and oxidative stress in mice with non-alcoholic steatohepatitis by regulating CFLAR-JNK pathway.
    Liu Y; Xu W; Zhai T; You J; Chen Y
    Acta Pharm Sin B; 2019 Jul; 9(4):745-757. PubMed ID: 31384535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease.
    Long JK; Dai W; Zheng YW; Zhao SP
    Mol Med; 2019 Jun; 25(1):26. PubMed ID: 31195981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. L-mimosine and hypoxia enhance angiopoietin-like 4 production involving hypoxia-inducible factor-1alpha: Insights from monolayer and spheroid cultures of dental pulp-derived cells and tooth slice cultures.
    Janjić K; Alhujazy U; Moritz A; Agis H
    Arch Oral Biol; 2018 Jan; 85():172-177. PubMed ID: 29100106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LB100 ameliorates nonalcoholic fatty liver disease
    Chen XY; Cai CZ; Yu ML; Feng ZM; Zhang YW; Liu PH; Zeng H; Yu CH
    World J Gastroenterol; 2019 Dec; 25(45):6607-6618. PubMed ID: 31832001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypoxia inducible factor-1 promotes liver fibrosis in nonalcoholic fatty liver disease by activating PTEN/p65 signaling pathway.
    Han J; He Y; Zhao H; Xu X
    J Cell Biochem; 2019 Sep; 120(9):14735-14744. PubMed ID: 31009107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of hypoxia-inducible factor-1 alpha in the regulation of plasminogen activator activity in rat knee joint chondrocytes.
    Zhu G; Tang Y; Liang X; Zheng M; Yang J; Zhou H; Li L; Qin T
    Osteoarthritis Cartilage; 2009 Nov; 17(11):1494-502. PubMed ID: 19490965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of Electroacupunctrue Combined with Dietary Control on Peroxisome Proliferator-activa- ted Receptor-α, and Liver Fatty Acid-binding Protein Levels in Non-alcoholic Fatty Liver Disease Rats].
    Zhang Y; Tang CL; Tian Y; Yuan HZ; Yang H; Tang NZ; Gao RQ; Cao J
    Zhen Ci Yan Jiu; 2015 Oct; 40(5):345-51. PubMed ID: 26669188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Downregulation of fatty acid oxidation by involvement of HIF-1α and PPARγ in human gastric adenocarcinoma and related clinical significance.
    Ezzeddini R; Taghikhani M; Salek Farrokhi A; Somi MH; Samadi N; Esfahani A; Rasaee MJ
    J Physiol Biochem; 2021 May; 77(2):249-260. PubMed ID: 33730333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemical hypoxia induces pro-inflammatory signals in fat-laden hepatocytes and contributes to cellular crosstalk with Kupffer cells through extracellular vesicles.
    Hernández A; Geng Y; Sepúlveda R; Solís N; Torres J; Arab JP; Barrera F; Cabrera D; Moshage H; Arrese M
    Biochim Biophys Acta Mol Basis Dis; 2020 Jun; 1866(6):165753. PubMed ID: 32126269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contribution of HIF-1α/BNIP3-mediated autophagy to lipid accumulation during irinotecan-induced liver injury.
    Shi C; Zhang Z; Xu R; Zhang Y; Wang Z
    Sci Rep; 2023 Apr; 13(1):6528. PubMed ID: 37085612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
    Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
    Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppression of miR-30a-3p Attenuates Hepatic Steatosis in Non-alcoholic Fatty Liver Disease.
    Wang DR; Wang B; Yang M; Liu ZL; Sun J; Wang Y; Sun H; Xie LJ
    Biochem Genet; 2020 Oct; 58(5):691-704. PubMed ID: 32419060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alisol A 24-Acetate Prevents Hepatic Steatosis and Metabolic Disorders in HepG2 Cells.
    Zeng L; Tang W; Yin J; Feng L; Li Y; Yao X; Zhou B
    Cell Physiol Biochem; 2016; 40(3-4):453-464. PubMed ID: 27889747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The HIF-2α/PPARα pathway is essential for liraglutide-alleviated, lipid-induced hepatic steatosis.
    Wang H; Wang L; Li Y; Luo S; Ye J; Lu Z; Li X; Lu H
    Biomed Pharmacother; 2021 Aug; 140():111778. PubMed ID: 34062416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatocyte-specific hypoxia-inducible factor-1α is a determinant of lipid accumulation and liver injury in alcohol-induced steatosis in mice.
    Nath B; Levin I; Csak T; Petrasek J; Mueller C; Kodys K; Catalano D; Mandrekar P; Szabo G
    Hepatology; 2011 May; 53(5):1526-37. PubMed ID: 21520168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic effect and autophagy regulation of myriocin in nonalcoholic steatohepatitis.
    Yang RX; Pan Q; Liu XL; Zhou D; Xin FZ; Zhao ZH; Zhang RN; Zeng J; Qiao L; Hu CX; Xu GW; Fan JG
    Lipids Health Dis; 2019 Oct; 18(1):179. PubMed ID: 31639005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coix lacryma-jobi Seed Oil Reduces Fat Accumulation in Nonalcoholic Fatty Liver Disease by Inhibiting the Activation of the p-AMPK/SePP1/apoER2 Pathway.
    Gu L; Zhang Y; Zhang S; Zhao H; Wang Y; Kan D; Zhang Y; Guo L; Lv J; Hao Q; Tian X; Liu C; Wang S; Han X
    J Oleo Sci; 2021 May; 70(5):685-696. PubMed ID: 33840662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.